New Cedars-Sinai center aims to advance the treatment of gastrointestinal and liver diseasesNovember 22, 2026
General Pheno Therapeutics granted two key patents protecting its selective GPR17 antagonist pipeline targeting neurological diseasesBy Healthcare Propulsion StaffNovember 18, 20260 Pheno Therapeutics Limited. (Pheno), a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for…